Cell proliferation and death: Forgotten features of chronic lymphocytic leukemia B cells

Best Practice and Research: Clinical Haematology

Volumn 20, Issue 3, 2007, Pages 399-413

  Chiorazzi, Nicholas ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

antigen; antigen receptor; apoptosis; autoantigen; B lymphocyte; cell death; cell proliferation; chronic lymphocytic leukemia; kinetics

Indexed keywords

B LYMPHOCYTE RECEPTOR; DNA; MITOGENIC AGENT;

APOPTOSIS; B LYMPHOCYTE; CELL DEATH; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CYTOLOGY; GENETIC DISORDER; HOMEOSTASIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; LEUKEMIA CELL; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; LYMPHOMA; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SAFETY; T LYMPHOCYTE;

ANTIGENS, CD; APOPTOSIS; B-LYMPHOCYTES; CELL DEATH; CELL PROLIFERATION; DNA REPLICATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC;

EID: 34547855136     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2007.03.007     Document Type: Review

References (83)

1. Dameshek W. Chronic lymphocytic leukemia - an accumulative disease of immunologically incompetent lymphocytes. Blood 29 4supplement (1967) 566-584
2. Rai K.R., and Patel D.V. Chronic lymphocytic leukemia. In: Hoffman R., Benz E., Shattil S., et al. (Eds). Hematology: basic principles and practice. 2nd ed. (1995), Churchill Livingstone, New York 1308-1321
3. Pileri S.A., Ascani S., Sabattini E., et al. The pathologist's view point. Part I-indolent lymphomas. Haematologica 85 12 (2000) 1291-1307
4. Andreef M. Flow cytometry in leukemia. In: Melamed M.R., and Mendelsohn M.L. (Eds). Flow cytometry and cell sorting (1990), Alan R. Liss, New York p. 697
5. Matutes E., and Polliack A. Morphological and immunophenotypic features of chronic lymphocytic leukemia. Reviews in Clinical and Experimental Hematology 4 1 (2000) 22-47
6. Ma Y., Mansour A., Bekele B.N., et al. The clinical significance of large cells in bone marrow in patients with chronic lymphocytic leukemia. Cancer 100 10 (2004) 2167-2175
7. Lampert I.A., Wotherspoon A., Van Noorden S., and Hasserjian R.P. High expression of CD23 in the proliferation centers of chronic lymphocytic leukemia in lymph nodes and spleen. Human Pathology 30 6 (1999) 648-654
8. Granziero L., Ghia P., Circosta P., et al. Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood 97 9 (2001) 2777-2783
9. Schmid C., and Isaacson P.G. Proliferation centres in B-cell malignant lymphoma, lymphocytic (CLL): an immunophenotypic study. Histopathology 24 5 (1994) 445-451
10. Caligaris-Cappio F. Role of the microenvironment in chronic lymphocytic leukaemia. British journal of haematology 123 3 (2003) 380-388
11. Pizzolo G., Chilosi M., Ambrosetti A., et al. Immunohistologic study of bone marrow involvement in B-chronic lymphocytic leukemia. Blood 62 6 (1983) 1289-1296
12. Fluckiger A.C., Rossi J.F., Bussel A., et al. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood 80 12 (1992) 3173-3181
13. Buske C., Gogowski G., Schreiber K., et al. Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand. Experimental Hematology 25 4 (1997) 329-337
14. Ghia P., Strola G., Granziero L., et al. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22. European journal of immunology 32 5 (2002) 1403-1413
15. Damle R.N., Ghiotto F., Valetto A., et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 99 11 (2002) 4087-4093
16. Rosenwald A., Alizadeh A.A., Widhopf G., et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. The Journal of Experimental Medicine 194 11 (2001) 1639-1647
17. Klein U., Tu Y., Stolovitzky G.A., et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. The Journal of Experimental Medicine 194 11 (2001) 1625-1638
18. Damle R.N., Batliwalla F.M., Ghiotto F., et al. Telomere length and telomerase activity delineate distinctive replicative features of the CLL subgroups defined by immunoglobulin V gene mutations. Blood 103 2 (2004) 375-382
19. Zupo S., Isnardi L., Megna M., et al. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood 88 4 (1996) 1365-1374
20. Lagneaux L., Delforge A., Bron D., et al. Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood 91 7 (1998) 2387-2396
21. Panayiotidis P., Jones D., Ganeshaguru K., et al. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. British Journal of Haematology 92 1 (1996) 97-103
22. Burger J.A., Tsukada N., Burger M., et al. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 96 8 (2000) 2655-2663
23. Bernal A., Pastore R.D., Asgary Z., et al. Survival of leukemic B cells promoted by engagement of the antigen receptor. Blood 98 10 (2001) 3050-3057
24. Zupo S., Massara R., Dono M., et al. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD. Blood 95 4 (2000) 1199-1206
25. Ranheim E.A., and Kipps T.J. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. The Journal of Experimental Medicine 177 4 (1993) 925-935
26. Deaglio S., Vaisitti T., Bergui L., et al. CD38 and CD100 lead a network of surface receptors relaying positive signals for CLL growth and survival. Blood 105 (2005) 3042-3050
27. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nature Immunology 5 10 (2004) 987-995
28. Orsini E., and Foa R. Cytokines and regulatory molecules in the pathogenesis and clinical course of B-cell chronic lymphocytic leukemia. 2nd ed. (2001), Marcel Dekker, Inc, New York
29. Burger J.A., and Kipps T.J. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107 5 (2006) 1761-1767
30. Flad G.D., Huber C., Bremer K., et al. Impaired recirculation of B lymphocytes in chronic lymphocytic leukemia. European Journal of Immunology 3 11 (1973) 688-693
31. Stryckmans P.A., Debusscher L., and Collard E. Cell kinetics in chronic lymphocytic leukaemia (CLL). Clinical Haematology 6 1 (1977) 159-167
32. Hultdin M., Rosenquist R., Thunberg U., et al. Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications. British Journal of Cancer 88 4 (2003) 593-598
33. Waldman F.M., Chew K., Ljung B.M., et al. A comparison between bromodeoxyuridine and 3H thymidine labeling in human breast tumors. Modern Pathology 4 6 (1991) 718-722
34. Gratzner H.G. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 218 4571 (1982) 474-475
35. Asher E., Payne C.M., and Bernstein C. Evaluation of cell death in EBV-transformed lymphocytes using agarose gel electrophoresis, light microscopy and electron microscopy. II. Induction of non-classic apoptosis ('para-apoptosis') by tritiated thymidine. Leukemia & Lymphoma 19 1-2 (1995) 107-119
36. Rocha B., Penit C., Baron C., et al. Accumulation of bromodeoxyuridine-labeled cells in central and peripheral lymphoid organs: minimal estimates of production and turnover rates of mature lymphocytes. European Journal of Immunology 20 8 (1990) 1697-1708
37. Reichard P. Interactions between deoxyribonucleotide and DNA synthesis. Annual Review of Biochemistry 57 (1988) 349-374
38. Cohen A., Barankiewicz J., Lederman H.M., and Gelfand E.W. Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. The Journal of Biological Chemistry 258 20 (1983) 12334-12340
39. Hellerstein M.K. Measurement of T-cell kinetics: recent methodologic advances. Immunology Today 20 10 (1999) 438-441
40. Neese R.A., Misell L.M., Turner S., et al. Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA. Proceedings of the National Academy of Sciences of the USA 99 24 (2002) 15345-15350
41. Neese R.A., Siler S.Q., Cesar D., et al. Advances in the stable isotope-mass spectrometric measurement of DNA synthesis and cell proliferation. Analytical Biochemistry 298 2 (2001) 189-195
42. Hellerstein M., Hanley M.B., Cesar D., et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nature Medicine 5 1 (1999) 83-89 [see comments]
43. McCune J.M., Hanley M.B., Cesar D., et al. Factors influencing T-cell turnover in HIV-1-seropositive patients. The Journal of Clinical Investigation 105 5 (2000) R1-R8
44. Mohri H., Perelson A.S., Tung K., et al. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. The Journal of Experimental Medicine 194 9 (2001) 1277-1287
45. Messmer B.T., Messmer D., Allen S.L., et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. The Journal of Clinical Investigation 115 3 (2005) 755-764
46. Zimmerman T.S., Godwin H.A., and Perry S. Studies of leukocyte kinetics in chronic lymphocytic leukemia. Blood 31 3 (1968) 277-291
47. Schiffer L.M., Chanana A.D., Cronkite E.P., et al. Lymphocyte kinetics in chronic lymphocytic leukaemia (CLL) studied by ECIB. British Journal of Haematology 17 4 (1969) 408
48. Theml H., Trepel G., Schick P., et al. Kinetics of lymphocytes in chronic lymphocytic leukemia: studies using continuous 3H-thymidine infusion in two patients. Blood 42 (1973) 623
49. Theml H., Love R., and Begemann H. Factors in the pathomechanism of chronic lymphocytic leukemia. Annual Review of Medicine 28 (1977) 131-141
50. Cheson B.D., Bennet J.M., Grever M., et al. National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87 12 (1996) 4990-4997
51. Damle R.N., Wasil T., Fais F., et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94 6 (1999) 1840-1847
52. Deaglio S., Vaisitti T., Aydin S., et al. In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia. Blood 108 4 (2006;15) 1135-1144
53. Calissano C., Damle R., Banapour T., et al. In vivo labeling of newly synthesized DNA suggests that the CD38+ fraction is enriched in proliferating cells within a clone of chronic lymphocytic leukemia B cells. Blood 108 11 (2006) 12a-13a
54. Damle R., Allen S., Rai K.R., and Chiorazzi N. CD38 expression identifies an active subset of proliferating cells within the clonal population in chronic lymphocytic leukemia patients (in vitro analysis). Blood 108 11 (2006) 13a
55. Zupo S., Cutrona G., Mangiola M., and Ferrarini M. Role of surface IgM and IgD on survival of the cells from B-cell chronic lymphocytic leukemia. Blood 99 6 (2002) 2277-2278
56. Lanham S., Hamblin T., Oscier D., et al. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood 101 3 (2003) 1087-1093
57. Pepper C., Ward R., Lin T.T., et al. Highly purified CD38(+) and CD38(-) sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal origin. Leukemia 21 4 (2007) 687-696
58. Lam K.P., Kuhn R., and Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90 6 (1997) 1073-1083
59. Woodland R.T., and Schmidt M.R. Homeostatic proliferation of B cells. Seminars in Immunology 17 3 (2005) 209-217
60. Cancro M.P. The BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation. Immunological Reviews 202 (2004) 237-249
61. Chiorazzi N., and Ferrarini M. B Cell Chronic Lymphocytic Leukemia: Lessons learned from studies of the B cell antigen receptor. Annual Review of Immunology 21 (2003) 841-894
62. Stevenson F.K., and Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 103 12 (2004) 4389-4395
63. Chiorazzi N., Rai K.R., and Ferrarini M. Chronic Lymphocytic Leukemia. The New England Journal of Medicine 352 8 (2005) 804-815
64. Schroeder Jr. H.W., and Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunology Today 15 6 (1994) 288-294
65. Fais F., Ghiotto F., Hashimoto S., et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. The Journal of Clinical Investigation 102 8 (1998) 1515-1525
66. Tobin G., Thunberg U., Johnson A., et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted V{lambda}2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 101 12 (2003) 4952-4957
67. Ghiotto F., Fais F., Valetto A., et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. The Journal of Clinical Investigation 113 7 (2004) 1008-1016
68. Messmer B.T., Albesiano E., Efremov D.G., et al. Multiple distinct sets of stereotyped antigen receptors indicate a key role for antigen in promoting chronic lymphocytic leukemia. The Journal of Experimental Medicine 200 (2004) 519-525
69. Tobin G., Thunberg U., Karlsson K., et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 104 9 (2004) 2879-2885
70. Widhopf II G.F., Rassenti L.Z., Toy T.L., et al. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 104 8 (2004) 2499-2504
71. Stamatopoulos K., Belessi C., Moreno C., et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood 109 1 (2007) 259-270
72. Sthoeger Z.M., Wakai M., Tse D.B., et al. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. The Journal of Experimental Medicine 169 1 (1989) 255-268
73. Borche L., Lim A., Binet J.L., and Dighiero G. Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood 76 3 (1990) 562-569
74. Herve M., Xu K., Ng Y.-S., et al. Unmutated and mutated chronic lymphocytic leukemia derive from common self-reactive B cell precursors despite expressing different antibody reactivity. The Journal of Clinical Investigation 115 (2005) 1636-1643
75. Chu C.C., Wang X.B., Hatzi K., et al. CLL antibodies comprised of stereotypic VH1-69, D3-16, and JH3 rearrangements immunoprecipitate cellular protein(s). Blood 108 11 (2006) 797a
76. Catera R., Hatzi K., Chu C.C., et al. Polyreactive monoclonal antibodies synthesized by some CLL cells recognize specific antigens on viable and apoptotic T cells. Blood 108 11 (2006) 796a
77. Hatzi K., Catera R., Ferrarini M., et al. B-cell chronic lymphocytic leukemia (CLL) cells expresss antibodies reactive with antigenic epitopes expressed on the surface of common bacteria. Blood 108 11 (2006) 12a
78. Niiro H., and Clark E.A. Regulation of B-cell fate by antigen-receptor signals. Nature Reviews. Immunology 2 12 (2002) 945-956
79. Petlickovski A., Laurenti L., Li X., et al. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells. Blood 105 12 (2005) 4820-4827
80. Dohner H., Stilgenbauer S., Benner A., et al. Genomic aberrations and survival in chronic lymphocytic leukemia. The New England Journal of Medicine 343 26 (2000) 1910-1916
81. Krober A., Seiler T., Benner A., et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100 4 (2002) 1410-1416
82. Ottaggio L., Viaggi S., Zunino A., et al. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression. Haematologica 88 7 (2003) 769-777
83. Lin K., Sherrington P.D., Dennis M., et al. Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia. Blood 100 4 (2002) 1404-1409